Pituitary gland: Medical therapy for acromegaly: Can we predict response?

Nature Reviews Endocrinology

Volumn 5, Issue 8, 2009, Pages 425-427

  Giustina, Andrea ^a,b   Porcelli, Teresa ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Montichiari Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; OCTREOTIDE; PEGVISOMANT; PROLACTIN; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; CANCER INHIBITION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; GROWTH HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOPHYSIS ADENOMA; MONOTHERAPY; NEUROSURGERY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SHORT SURVEY; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ACROMEGALY; DOPAMINE AGONISTS; FOLLICLE STIMULATING HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUTEINIZING HORMONE; PROLACTIN; SOMATOSTATIN;

EID: 70349199233     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.146     Document Type: Short Survey

References (10)

1. Sherlock, M. et al. Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists ana gement: anupdate. J. Clin. Endocrinol. Metab. 94,1509-1517 (2009).
2. Melmed,s. et al. Consensus st atement: management: an update. J. Clin. Endocrinol. Metab. 94,1509-1517 (2009).
3. Melmed.S. et al. Consensus statement: medical management of acromegaly. Eur. J. Endocrinol. 153, 737-740 (2005).
4. Freda, PU. et al. Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. J. Clin. Endocrinol. Metab. 90,4465-4473 (2005).
5. Gola, M., Bonadonna, S., Mazziotti, G., Amato, G. & Giustina, A. Resistance to somatostatin analogs in acromegaly: an evolving concept? J. Endocrinol. Invest. 29,86-93 (2006).
6. Jaffe, C. A. & Barkan, A. L. Treatment of acromegaly with dopamine agonists. Endocrinol. Metab. Clin. North Am. 21,713-735 (1992).
7. Giustina, A. et al. Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85,526-529 (2000).
8. Colao, A. et al. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J. Clin. Endocrinol. Metab. 12 55-1263 (2009).
9. Bianchi.A. et al. Influence of growth hormone receptor D3 and full-length isoforms on biochemical treatment outcomes in acromegaly. J. Clin. Endocrinol. Metab. 94, 2015-2022 (2009).
10. Fusco, A. et al. Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas. J. Clin. Endocrinol. Metab. 93,2746-2750 (2008).